Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock Price

CRBPStock

$11.31+9.19%52W

Market Cap$218.75M

P/E—

PEG Ratio—

Div yield—

Beta2.59

CRBP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)33.02%

Price vs S&P 500 (4W)14.61%

VGM Score44.47

Book Value / Share (Quarterly)$5.48

P/TBV (Annual)0.58x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-4.64

Price vs S&P 500 (YTD)19.37%

Net Profit Margin (TTM)-2838.71%

EPS (TTM)$-6.17

10-Day Avg Trading Volume0.59M

EPS Excl Extra (TTM)$-6.17

EPS (Annual)$-3.64

ROI (Annual)-28.08%

Net Profit Margin (5Y Avg)-2138.37%

Cash / Share (Quarterly)$6.32

ROA (Last FY)-25.66%

EBITD / Share (TTM)$-6.37

ROE (5Y Avg)-324.10%

Operating Margin (TTM)-4309.68%

Cash Flow / Share (Annual)$-3.66

P/B Ratio1.93x

P/B Ratio (Quarterly)1.70x

Net Income / Employee (Annual)$-1,111,100

EV / Revenue (TTM)111.95x

Net Interest Coverage (TTM)-14.44x

ROA (TTM)-74.22%

EPS Incl Extra (Annual)$-3.64

Current Ratio (Annual)8.07x

Quick Ratio (Quarterly)5.62x

3-Month Avg Trading Volume0.46M

52-Week Price Return9.19%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.07

P/S Ratio (Annual)223.74x

Asset Turnover (Annual)0.01x

52-Week High$20.56

Operating Margin (5Y Avg)-2440.93%

EPS Excl Extra (Annual)$-3.64

CapEx CAGR (5Y)-57.07%

Tangible BV CAGR (5Y)-10.60%

26-Week Price Return44.26%

Quick Ratio (Annual)7.92x

13-Week Price Return-7.12%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.71x

Enterprise Value$173.52M

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)24.74%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-5186.36%

Cash / Share (Annual)$9.27

3-Month Return Std Dev86.04%

Net Income / Employee (TTM)$-2,830,600

ROE (Last FY)-28.08%

Net Interest Coverage (Annual)-12.93x

EPS Basic Excl Extra (Annual)$-3.64

Receivables Turnover (TTM)1.11x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-6.17

ROI (TTM)-87.05%

P/S Ratio (TTM)127.03x

Pretax Margin (5Y Avg)-2138.37%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$7.91

Price vs S&P 500 (52W)-9.12%

Year-to-Date Return31.33%

5-Day Price Return6.05%

EPS Normalized (Annual)$-3.64

ROA (5Y Avg)-79.97%

Net Profit Margin (Annual)-5186.36%

Month-to-Date Return19.18%

Cash Flow / Share (TTM)$-10.98

EBITD / Share (Annual)$-4.40

Operating Margin (Annual)-6362.50%

LT Debt / Equity (Annual)0.48x

ROI (5Y Avg)-271.09%

LT Debt / Equity (Quarterly)2.67x

EPS Basic Excl Extra (TTM)$-6.17

P/TBV (Quarterly)61.73x

P/B Ratio (Annual)0.97x

Pretax Margin (TTM)-2838.71%

Book Value / Share (Annual)$8.38

Price vs S&P 500 (13W)-9.92%

Beta2.59x

Revenue / Share (TTM)$0.00

ROE (TTM)-87.05%

52-Week Low$7.12

vGradeD

mGradeC

vgmGradeC

CRBP Earnings Surprise History

Q2 25-1.44est. -1.33

Q3 25-1.90est. -1.71

Q4 25-1.25est. -1.58

Q1 26-1.23est. -1.22

Q2 26-1.81est. -1.24

CRBP Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.38

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
CRBPCorbus Pharmaceuticals Holdings, Inc.	D	—	C	$11.31
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals is a biopharmaceutical company developing precision therapeutics for oncology and metabolic disorders. Its pipeline includes CRB-701, an antibody-drug conjugate targeting Nectin-4 in cancer; CRB-601, an anti-integrin antibody designed to block TGF activation; and CRB-913, a CB1 receptor inverse agonist for obesity. These programs target validated biological pathways to address serious diseases.